Observational study on the daily consumption of alcoholic and non-alcoholic beverages

UMIN ID: UMIN000056098

Registered date:11/11/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Healthy subjects
• Date of first enrollment: 2024/10/23
• Target sample size: 100
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: Lifestyle Survey
• Secondary Outcome: Beverage-related questionnaire

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 40years-old
• Gender: Male and Female
• Exclude criteria: 1. Taking medication or Chinese medication (except for the dugs as needed) 2. Current of history of serious diseases such as heart, liver, kidney, gastrointestinal tract. 3. Those who has pollinosis (autumn pollen) or allergic rhinitis (seasonal/perennial) 4. Under diet of exercise therapy under the supervision of a doctor 5. Those who regularly uses any commercially available drug and quasi-drug, food for specified health use, food that affects autonomic nervous system, and sleep (however, the person will be eligible if he/she can stop using it during the study period after provision of the informed consent) 6. Excessive consumption of alcohol (alcohol equivalent 60g or more /day) 7. Irregular diet, shift worker, night shift, irregular life rhythm 8. Those who has participated another clinical study within 1 month prior to provision of the informed consent , other than the psychological evaluation study conducted by AQI,or is currently participating in it, or will participate in it during the study period or within 4 weeks after the end of the study 9. Those who will be possibly under significant stress of any life event such as moving, changing his/her job, and separation from a close relative, within 3 months prior to provision of the informed consent, or will have such a life event during the study period 10. Current of history of drug and/or food allergies 11. Those who is unable to drink alcohol constitutionally 12. Those who are breastfeeding, pregnant, possibly pregnant, or intend to become pregnant during the study period. 13. Judged by the investigator to be unsuitable for participating in this study

Related Information

• Primary Sponsor: Macromill, Inc.
• Source(s) of Monetary Support: Asahi Quality & Innovations, Ltd